← Clinical Evidence

SRC-e6c1e0c8b7e3 Backstrom D 2022

Evidence source and scope

Bäckström D, Granåsen G, Jakobson Mo S, et al. Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study. Brain Communications. 2022. DOI 10.1093/braincomms/fcac040

This note indexes a cited or audit-added source. It may be an original study, review, guideline, form or methods reference. Treat the specific design and the evidence below as authoritative; a source note is not automatically a primary study.

DOI: 10.1093/braincomms/fcac040

Bibliographic record from the original reports

Access labels embedded in these original reference strings are historical. Current access and exact checked components are stated separately below.

Bäckström D, Granåsen G, Jakobson Mo S, et al. Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study. Brain Communications. 2022. DOI 10.1093/braincomms/fcac040

Bäckström DC, Granåsen G, Mo SJ, et al. Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study. Brain Communications. 2022. DOI 10.1093/braincomms/fcac040

Conditions: COND-PD Parkinson’s disease

Scoped audit evidence

These are source- and component-level audit summaries as of 3 October 2026. Access and comparison scope can differ by report; none certifies every result or the underlying raw data.

Parkinson’s disease — gait

GaitP109/P150-152:143PD64dementiacases10years;univariatePIGDHR3.2(1.8-5.7);finalclinical/CSFAUC.86notgait-specific;PIGDnotretained;NYPUMoverlap;developmentonly. Source locator: s2StudyPopulation;s3Clinical;s6Statistical;s9ResultsTable3andFigure4 Limit: FullPDFnotrequired forcheckedtexttables;firstyearposturalinstability differentfromfixedbaseline sign.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance

GaitP109/P150-152:143PD64dementiacases10years;univariatePIGDHR3.2(1.8-5.7);finalclinical/CSFAUC.86notgait-specific;PIGDnotretained;NYPUMoverlap;developmentonly. Source locator: s2StudyPopulation;s3Clinical;s6Statistical;s9ResultsTable3andFigure4 Limit: FullPDFnotrequired forcheckedtexttables;firstyearposturalinstability differentfromfixedbaseline sign.

Limitations: Only scoped comparisons, not whole-paper certification.

Parkinson’s disease — balance1

GaitP109/P150-152:143PD64dementiacases10years;univariatePIGDHR3.2(1.8-5.7);finalclinical/CSFAUC.86notgait-specific;PIGDnotretained;NYPUMoverlap;developmentonly. Source locator: s2StudyPopulation;s3Clinical;s6Statistical;s9ResultsTable3andFigure4 Limit: FullPDFnotrequired forcheckedtexttables;firstyearposturalinstability differentfromfixedbaseline sign.

Limitations: Only scoped comparisons, not whole-paper certification.

Reports citing this source

Update record

Updating the wiki · Evidence and status guide